Promising trial of drug to treat low grade serous ovarian cancer

There have been promising results from a trial for low grade ovarian cancer, revealed at the ESMO conference 2019 (European Society for Medical Oncology).

The randomised trial of a drug called trametinib – previously used to treat melanoma – was shown to have an increased response rate compared with standard treatments.

Read the full article

Further information

Comments (0)

Comment (maximum 3500 characters) *

Add a picture

Notify me when someone makes a comment

First name *

Last name *

Email *

Which country do you live in?

Please enter your postcode*

Address line 1

Address line 2

Town or city

Keeping In Touch

We would love to keep you posted with news, activities and how you can help in other ways. We'll never sell or swap your details with anybody else. You are free to change your mind at any time. Please indicate how you are happy to be contacted by using the tick boxes below.

Please note that if you are signing up for an online event being run by our partner Ovarian Cancer Action, the contact details that you provide will be passed on to them, so that they can send you information about your event and keep in touch in the ways that you have indicated that you are happy with.

Via email

Via telephone

Via SMS

Via post

Which country do you live in?

Please enter your postcode*

Address line 1

Address line 2

Town or city

Your Privacy

We will always store your personal details securely. We'll use them to provide the service that you have requested, and communicate with you in the way(s) that you have agreed to. Your data may also be used for analysis purposes, to help us provide the best service possible. For full details see our Privacy Policy

By submitting this form you are agreeing to our terms and conditions

Latest

Mastectomy Chatter

Join Christen Williams, our friend from BRCA Chatter, to discuss everything related to risk-reducing mastectomies. From how to prepare your body for surgery, what to take to hospital, what to expect from recovery- bring your questions!
Lynch Syndrome Q&A

For this session we’re joined by Dr Anju Kulkarni, Consultant Clinical Geneticist at Guy’s and St Thomas’ Hospital, who will be answering all your questions about Lynch syndrome.
Hormone Replacement Therapy and inherited cancer risk

Dr Louise Newson joins us to discuss HRT for people who have inherited a high-risk faulty gene or are worried about their family history of cancer impacting their options around the menopause.
Stoma group

Our new online stoma group is a friendly space for anyone living with a colostomy, ileostomy or urostomy to chat with others in similar circumstances.